Sequential anti-CD19 directed chimeric antigen receptor modified T-cell therapy (CART19) and PD-1 blockade with pembrolizumab in patients with relapsed or refractory B-cell non-Hodgkin lymphomas Meeting Abstract


Authors: Chong, E. A.; Svoboda, J.; Nasta, S. D.; Landsburg, D. J.; Winchell, N.; Napier, E.; Mato, A. R.; Melenhorst, J. J.; Ruella, M.; Lacey, S. F.; June, C. H.; Schuster, S. J.
Abstract Title: Sequential anti-CD19 directed chimeric antigen receptor modified T-cell therapy (CART19) and PD-1 blockade with pembrolizumab in patients with relapsed or refractory B-cell non-Hodgkin lymphomas
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454842803219
PROVIDER: wos
DOI: 10.1182/blood-2018-99-119502
Notes: Meeting Abstract: 4198 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato
Related MSK Work